Thousands of HIV/AIDS advocates “marched through Vienna’s city centre on Tuesday evening, demanding more respect for human rights in the fight against HIV,” Agence France-Presse reports.
Global Health Conferences and Meetings
AIDS 2010 Studies, Releases: PMTCT, Treating Children, Male Circumcision; National Prevention Programs; IDUs
“In parts of Africa, only about half of babies born to mothers with HIV receive the HIV prevention drug nevirapine,” according to a study published Wednesday, HealthDay News/U.S. News & World Report reports.
AIDS 2010 Opinions: U.S. AIDS Funding; Human Rights And HIV; Invest In Primary Care; Microbicide Gel’s Possibilities
U.S. Should Spend More To Combat HIV Globally “HavingÂ met President [Barack] Obama, I’m confident that he’s a man of conscience who shares my commitment to bringing hope and care to the world’s poor. But I am saddened by his decision to spend less than he promised to treat AIDS patients…
Blog: Global AIDS Coordinator Goosby Speaks About UgandaÂ HIV TreatmentÂ As part of a series in advance of AIDS 2010, theÂ “Science Speaks”Â blog features an interview with U.S. Global AIDS Coordinator Eric Goosby “about his expectations for the conference, what was behind the Uganda problem with shortages of AIDS medicine, and whether…
“Having HIV appears to be associated with a greater risk of death, even when the immune system is relatively robust and patients have not started treatment,” according to a study published Friday in the Lancet, MedPage Today reports (Smith, 7/15).
Opinions: Haitian Rebuilding; Nuclear State Vaccine Initiatives; HIV Rights Abuses In China; HIV Vaccine
Post-Earthquake RecoveryÂ In Haiti ‘Stalled’ The “paltry scale of the Pentagon’s reconstruction endeavor [in Haiti]Â – 1.6 million people displaced and the American military is contributing a few classrooms? — is emblematic of the international response,” columnist Dana Milbank writes in a Washington Post opinion piece. “Only 2 percent of promised reconstruction…
Ahead Of AIDS 2010, Lancet Issue Explores ARV Therapy, Gender Inequity Looking ahead to AIDS 2010Â which will be held in Vienna, Austria, July 18-23, a Lancet editorial writes that 2010 marks “the deadline set by global leaders to achieve universal access to HIV prevention, treatment, and care. Sadly, the world…
MedPage Today examines recent HIV prevention developments, in a 2010 year in review piece, beginning with the announcement at the International AIDS Conference in July that a microbicide gel used by women before and after sex reduced HIV infection by 39 percent.
“A declaration calling for global support to end the AIDS epidemic was announced [Tuesday] by the International AIDS Society (IAS) and the University of California, San Francisco (UCSF),” an IAS press release (.pdf) reports. “The ‘Washington, D.C. Declaration,’ which seeks to build broad support for beginning to end the AIDS epidemic through a nine-point action plan, will be the official declaration of the XIX International AIDS Conference (AIDS 2012),” which “will take place in Washington, D.C., from 22 to 27 July 2012” (7/10).
GlobalPost’s “Global Pulse” blog examines questions surrounding the use of the antiretroviral Truvada for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV infection among people at high risk, as studies released and panel discussions held last week at the XIX International AIDS Conference (AIDS 2012) “raised concerns about the drug’s effect on the future of the AIDS fight.” According to the blog, “Leaders in the fight against AIDS are trying to work through these issues and figure out the best way to make use of Truvada as prevention.” The blog notes that the WHO last week “released a set of guidelines for how to use PrEP in demonstration projects” and quotes AVAC Director Mitchell Warren, AIDS Healthcare Foundation President Michael Weinstein, amfAR Vice President and Director of Public Policy Chris Collins, and Black AIDS Institute President and CEO Phill Wilson (Judem, 7/27).